Approval · Notice of Compliance 22838 · 2019
SEGLUROMET: Notice of Compliance 22838
Issued October 30, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22838
- Date
- October 30, 2019
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEGLUROMET | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- ERTUGLIFLOZIN 2.5 MG per TAB
- METFORMIN HYDROCHLORIDE 1,000 MG per TAB
- ERTUGLIFLOZIN 7.5 MG per TAB